Table 4.
Prognostic factors | HR | 95% CI | P value |
---|---|---|---|
Gender (male/female) | 1.297 | 0.954–1.762 | 0.097 |
KPS (<80/≥80) | 2.087 | 1.539–2.831 | <0.001 |
Metachronous/Synchronous | 0.685 | 0.489–0.961 | 0.028 |
ECM (N/Y) | 0.749 | 0.054–1.012 | 0.060 |
Histology (non-adenocarcinoma/adenocarcinoma) | 1.303 | 1.114–1.524 | 0.001 |
MST median survival time, KPS Karnofsky performance status, ECM extracranial metastases